UNIGE document Scientific Article
previous document  unige:103247  next document
add to browser collection
Title

Size Exclusion Chromatography of Protein Biopharmaceuticals: Past, Present and Future
Authors
Fekete, Szabolcs
Goyon, Alexandre
Veuthey, Jean-Luc
Guillarme, Davy
Published in American Pharmaceutical Review. 2018, p. 1-4
Abstract Size exclusion chromatography (SEC) is a historical technique, routinely applied for the separation of species possessing different molecular masses (sizes). It is considered as a reference method for the qualitative and quantitative analysis of protein aggregates. In the last few years,several improvements were brought to high performance SEC (HP-SEC or conventional SEC) in terms of particle size, inertness and column dimension. Today, SEC columns of smaller dimensions packed with sub-3 μm particles (also known as ultra-high performance SEC (UHPSEC)) are used, to obtain faster and better separation compared to HP-SEC. This paper discusses the possibilities and limitations of both HP-SEC and UHP-SEC and also describes some possible directions for future applications related to protein biopharmaceuticals analysis.
Keywords Biopharmaceuticals — Size-exclusion chromatography — Aggregate — Monoclonal — Antibody — Antibody drug conjugate — Fusion proteins
Full text
Article (Published version) (642 Kb) - public document Free access
Structures
Faculté des sciences / Section des sciences pharmaceutiques
Research group Sciences analytiques
Citation
(ISO format) 		FEKETE, Szabolcs et al. Size Exclusion Chromatography of Protein Biopharmaceuticals: Past, Present and Future. In: American Pharmaceutical Review, 2018, p. 1-4. https://archive-ouverte.unige.ch/unige:103247

686 hits

431 downloads

Contact an author

Update request

Update

Deposited on : 2018-03-28

Export document
Format :
Citation style :